Pharmacodynamic effects of a 6-hour regimen of enoxaparin in patients undergoing primary percutaneous coronary intervention (PENNY PCI Study) - Sumaya, W; Parker, W AE; Fretwell, R (Thromb Haemost, 2018)
, et al.